Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $8.1200 (0.87%) ($8.1200 - $8.1200) on Thu. Apr. 23, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.38% (three month average) | RSI | 63 | Latest Price | $8.1200(0.87%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -0.3% a day on average for past five trading days. | Weekly Trend | ANPC advances 1.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) PCY(9%) XLB(9%) IPO(8%) LIT(8%) FXI(7%) | Factors Impacting ANPC price | ANPC will decline at least -2.69% in a week (0% probabilities). SHY(-13%) XLU(-6%) XLP(-5%) XBI(-5%) IBB(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.69% (StdDev 5.38%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.1(0.25%) | 10 Day Moving Average | $8.15(-0.37%) | 20 Day Moving Average | $8.03(1.12%) | To recent high | -27.8% | To recent low | 14.9% | Market Cap | $69m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |